MedPath
HSA Approval

OVA-MIT TABLET 50 mg

SIN06399P

OVA-MIT TABLET 50 mg

OVA-MIT TABLET 50 mg

July 4, 1991

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

G03GB02

clomifene

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

CLOMIFENE CITRATE

50 mg

Clomifene

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OVA-MIT TABLET 50 mg - HSA Approval | MedPath